Literature DB >> 12681144

[Is there a relationship between the assessment of coronary risk on the Framingham and Sheffield tables and the sixth report of the Joint National Committee? Relationship between tables of coronary risk].

L Viñas Cabrera1, A Orti Llaveria, C Aguilar Martín, J M Pepió Villaubí, V Rubio Carque, M Miravalls Figuerola.   

Abstract

OBJECTIVES: To find the distribution of coronary risk (CR) in the various groups of hypertense patients in the Joint National Committee (JNC VI), using both the Framingham and Sheffield tables, and to assess whether there is a relationship between the different scales used.
DESIGN: Descriptive study.
SETTING: Tortosa Oeste Health District, Tarragona. Spain. PARTICIPANTS: Rural population between 30 and 74 years old with Hypertension, but without any background of cardiovascular pathology. MAIN MEASUREMENTS: The variables studied corresponded to the Anderson table in the Framingham study, the Sheffield table and the JNC VI one. Concordance was assessed with the kappa coefficient.
RESULTS: 148 hypertense patients with an average age of 62, 63.5% of whom were women, were studied. 23% had high CR on the Framingham, and 42.1% on the Sheffield. Distribution of the sample according to the stratification of the JNC VI was: A, 16.2%; B, 51.4%, and C, 32.4%. High risk on the Framingham in the various groups of the JNC VI was: A, 0%; B, 9.2%, and C, 56.3% (kappa, 0.533). High risk on the Sheffield in the groups of the JNC VI ran at: A, 4.2%; B, 41.3%, and C, 66.7% (kappa, 0.324).
CONCLUSIONS: There was moderate concordance between the Framingham tables and the JNC VI for calculation of CR in our population.

Entities:  

Mesh:

Year:  2003        PMID: 12681144      PMCID: PMC7679682          DOI: 10.1016/s0212-6567(03)79182-3

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  17 in total

1.  Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors:  E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal:  BMJ       Date:  2000-03-11

2.  Estimating cardiovascular risk for primary prevention: outstanding questions for primary care.

Authors:  J Robson; K Boomla; B Hart; G Feder
Journal:  BMJ       Date:  2000-03-11

3.  [Preventive cardiovascular recommendations: practical applications of cardiovascular risk. Group for Cardiovascular Prevention of the PAPPS].

Authors:  F Villar Alvarez; A Maiques Galán; C Brotons Cuixart; J Torcal Laguna; A Lorenzo Piqueres; J Vilaseca Canals; J R Banegas Banegas; F Rodríguez Artalejo; V Gil Guillén
Journal:  Aten Primaria       Date:  1999-12       Impact factor: 1.137

4.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

5.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

6.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

7.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

Authors:  D Wood; G De Backer; O Faergeman; I Graham; G Mancia; K Pyörälä
Journal:  Atherosclerosis       Date:  1998-10       Impact factor: 5.162

8.  Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.

Authors:  L E Ramsay; I U Haq; P R Jackson; W W Yeo; D M Pickin; J N Payne
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

9.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

Review 10.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.